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Abstract
Background: HIV lipodystrophy syndrome is a recognized complication of potent antiretroviral
therapy and is characterized by often dramatic changes in various body fat stores, both central and
peripheral. Given prior findings of heightened body image dysphoria among HIV-infected men with
lipodystrophy as compared to HIV-infected men without lipodystrophy, we sought to determine
body image among HIV-infected and HIV-negative women and to determine the relationship of HIV
and lipodystrophy with body image. Our a priori hypothesis was that women with HIV and
lipodystrophy would have significantly poorer body image as compared to women without HIV and
to women with HIV without lipodystrophy.
Results: 116 women responded to two previously validated self-report instruments (Body Image
Quality of Life Index (BIQLI) and the Situational Inventory of Body-Image Dysphoria – Short Form
(SIBID-S)) on body image. 62 (53% subjects) HIV-infected women were recruited at the university-
based HIV clinic. 54 (47% subjects) HIV-negative female controls were recruited from another
study evaluating bone density in otherwise healthy controls. 96% identified their sexual orientation
as women having sex with men. Among the HIV-infected group, 36 reported the presence of
lipodystrophic characteristics and 26 reported no lipodystrophic changes. Agreement regarding the
presence of lipodystrophy between physician and subject was 0.67 as measured by the kappa
coefficient of agreement. Compared to HIV-negative women, HIV-positive women demonstrated
poor body image as measured by BIQLI (p = 0.0009). Compared with HIV-infected women who
denied lipodystrophy, HIV-infected women with self-reported lipodystrophy demonstrated poor
body image as measured by BIQLI (p = 0.02) and SIBID-S scales (p = 0.001).
Conclusion: We demonstrate that HIV and lipodystrophy status among women is associated with
poor body image. Universal efforts should be made in the HIV medical community to recognize
body image issues particularly among persons affected by lipodystrophy so that appropriate
intervention and support may be provided.
Background
Although HIV infection in the current era of highly active
antiretroviral therapy (HAART) has become a survivable
and chronic condition, multi-drug regimens pose signifi-
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cant potential metabolic side effects. HAART has been
associated with significant changes in body habitus in
many patients. The HIV lipodystrophy syndrome encom-
passes two different patterns of changes in central and
peripheral body fat stores, both of which are associated
with specific antiretroviral agents. Increased visceral adi-
posity, hypertrophy of the posterior cervical fat pad ("buf-
falo hump") and increases in female breast fat is typically
associated with agents of the protease inhibitor class [1],
while subcutaneous fat atrophy of the extremities and face
have been described primarily with agents in the nucleo-
side reverse transcriptase inhibitor class[2].
Many studies have demonstrated impaired psychosocial
functioning in patients with the lipodystrophy syndrome
as well as a negative impact on their quality of life and sex-
ual behavior [3-7]. We previously reported notable differ-
ences in body image measures among HIV-infected men
according to lipodystrophy status [8]. Prior research dem-
onstrating notable gender differences in body image per-
ception [9-11] suggests that body image studies among
mixed male-female populations should control for gender
confounding of results or evaluate gender groups sepa-
rately. In the current study, we investigated body image
among HIV-infected and HIV-negative women. Our a pri-
ori hypothesis was that women with HIV infection would
have significantly worse body image dysphoria and lower
body image related quality of life as compared to HIV-
negative controls. Similarly, we proposed that women
with HIV infection and lipodystrophy would have lower




Ninety-seven percent of approached patients agreed to
participate, and one hundred and sixteen women partici-
pated in our survey study. Sixty-two women were HIV-
positive. Ethnic composition of the entire cohort was 34%
Hispanic, 10% black, 45% white, 8% Asian, 3% other.
Demographic data are displayed in Table 1. There were no
differences in age or sexual orientation according to HIV
status; however, there was less Caucasian representation
among the HIV-infected population as compared to HIV-
negative control (p = 0.01). Among HIV-infected women,
median CD4 count was higher (p = 0.02) and median HIV
viral load (p = 0.003) was lower in women with self-
reported lipodystrophy, as compared to HIV-positive
women without lipodystrophy. AIDS status did not differ
between HIV-positive groups (p = 0.48).
Lipodystrophy assessment results
Concordance between physician and self-determination
of lipodystrophy status among HIV-infected women was
substantial, as determined by the kappa coefficient of
agreement (κ = 0.67).
Body image and HIV and lipodystrophy status
HIV and self-reported lipodystrophy status were associ-
ated with body image subscales (Table 1). HIV-positive
women, particularly HIV-positive women with lipodys-
trophy, had lower reported body image related quality of
life scores compared to HIV-negative controls (p=0.0009).
HIV-positive women with self-reported lipodystrophy
reported higher body image dysphoria (SIBID-S scores)
compared to HIV-positive women without lipodystrophy
and HIV-negative women.  Compared with HIV-infected
women who denied lipodystrophy, HIV-infected women
with self-reported lipodystrophy demonstrated poor body
image as measured by BIQLI (p=0.02) and SIBID-S scales
(p=0.001).
Similarly, among HIV-positive women, physician rated
lipodystrophy was significantly associated with both body
image subscale scores. Of the HIV-infected women, 38
women demonstrated clinical evidence of lipodystrophy;
24 did not. HIV-positive women with clinical lipodystro-
phy had significantly (p = 0.009) lower BIQLI scores
(median (IQR): -0.7 (-1.2, 0.04)) as compared to HIV-
infected women who did not have clinical lipodystrophy
(0.2 (-0.7, 0.8). HIV-positive women with clinical lipod-
ystrophy also reported higher SIBID-S scores as compared
to HIV-infected women without clinical lipodystrophy
(2.3 (1.6, 2.8) vs. 1.5 (0.5, 2.3), p = 0.005).
22% of HIV-infected women with self-reported lipodys-
trophy as compared to 0% of HIV-infected women with-
out lipodystrophy believed that others knew their HIV
disease status based solely on their appearance (p =
0.003).
Among HIV-positive women, specific patient-reported
lipodystrophy changes (i.e. fat atrophy or hypertrophy)
were also associated with body image scales (Table 2). In
particular, fat changes at the face, neck, breasts, abdomen,
and arms were significantly associated with SIBID-S scores
according to pair wise comparisons between fat change
groups and no change groups. Only fat changes at the
abdomen and breasts were significantly associated with
BIQLI scores.
Multiple linear regression analyses
Multiple linear regression analysis identified significant
associations between HIV status and body changes caused
by chronic disease, and poor body image scores. In partic-
ular, positive HIV status was associated with lower body
image related quality of life, and presence of body changes
caused by any chronic disease was associated with greater
body image dysphoria. Results are displayed in Table 3.AIDS Research and Therapy 2006, 3:17 http://www.aidsrestherapy.com/content/3/1/17
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Among the HIV-positive group, controlling for ethnicity,
multiple regression analyses were also performed to deter-
mine which site-specific patient-identified fat changes (as
identified by prior notable associations demonstrated on
pair-wise comparisons) predicted situational anxiety and
affected body image quality of life. Significant associa-
tions between arm atrophy (reference = arm hypertrophy
or no change, β = -0.79, p = 0.003), leg atrophy (reference
= leg hypertrophy or no change, β = +0.69, p = 0.004), and
breast hypertrophy (reference = breast atrophy or no
change, β = -0.43, p = 0.03) and BIQLI scores were identi-
fied (whole model R2 = 0.32, p = 0.008). Likewise, signif-
icant associations were found between arm atrophy
(reference = arm hypertrophy or no change, β = +0.57, p =
0.009) and leg atrophy (reference = leg hypertrophy or no
change, β = -0.35, p = 0.07), and SIBID-S scores (whole
model R2 = 0.39, p = 0.0006).
Discussion
We performed an observational study among HIV-
infected and HIV-negative women to determine whether
HIV status and self-perceived lipodystrophy status affects
body image and quality of life. Our findings suggest that
HIV status and somatic changes interpreted as lipodystro-
phy are associated with body image in women.
Body image encompasses an individual's body-related
self-perceptions and self-attitudes, and is linked to self
esteem, interpersonal confidence, eating, exercise, and
grooming behaviors, sexual experiences, and emotional
stability [12,13]. Diagnosis with a chronic disease can
have detrimental effects on self esteem and body image
[14]. In our cohort, we demonstrate that diagnosis with
HIV disease has a negative effect on body image related
quality of life among women. Alterations in body appear-
ances can similarly have significant effects on psychoso-
cial well-being and quality of life. Evidence of negative
interactions between body changes and body image has
already been demonstrated in HIV-infected men with
AIDS wasting [15] and with lipodystrophy [8]. In this
study, we also demonstrate evidence of detrimental con-
sequences on body image measures (greater body dyspho-
ria and lower body image related quality of life) among
HIV-infected women who perceive that they manifest
lipodystrophy body changes.
Studies indicate that the typical Western society female
prefers a thin body at all areas including chest, abdomen,
and limbs [16-18]. In accordance, our data demonstrated
that reduction in leg fat and breast size was associated
with improvements in body image measures. However,
regression modeling also suggested that reduction in arm
fat was associated with greater body image dysphoria and
lower body image related quality of life. One possible
explanation might be that loss of fat in the leg region
increases definition of muscles and results in an apparent
"toned" appearance, while loss of fat in the arm region
may lead to an atrophic appearance and suggestion of
physical inactivity or lack of physical fitness. Our findings
of increased desirability of fat reduction at the leg com-
pared to the arm in Western culture is supported by sur-
gery data from the United States demonstrating that the
most common sites of liposuction are located at the leg
(hip, thigh, knee, and calf) [19].
Table 1: Population Demographics
Entire Cohort HIV + with LipodystrophyΩ HIV+ without LipodystrophyΩ HIV-Control p-value **
Number of persons 116 36 26 54
Age (years)* 40 (33, 48) 43 (36, 50) 37 (31, 45) 40 (34, 48) 0.18¥
Race (white: non-white) 53: 63 16: 20 6: 20 31: 23 0.01Σ
Sexual Orientation (heterosexual: not) 111:5 33:3 26:0 52:2 0.27Σ
SIBID-S score* 2.3 (1.8, 2.8) 1.3 (0.5, 2.3) 1.4 (0.6, 2.4) 0.002¥
BIQLI score* -0.7 (-1.2, 0.2) 0 (-0.6, 0.6) 0.7 (-0.5, 2) 0.0008¥
HIV + with LipodystrophyΩ HIV + without LipodystrophyΩ p-value ▲
CD4 count (cells/μL)* 626 (444, 742) 430 (234, 588) 0.02¥
Log10 HIV viral load (copies/mL)* 2.6 (2.6, 2.8) 3.7 (2.6, 4.6) 0.003¥
AIDS (Yes:No) 14:22 9:17 0.48Σ
Believe that appearance reveals HIV status (%) 22% 0% 0.003Σ
*Expressed as median (interquartile range).
▲Between HIV+ lipodystrophy vs. HIV+ non-lipodystrophy groups.
**Statistical comparisons among all 3 groups.
ΩAs reported by the patient.
¥p-value by Kruskal-Wallis rank sum test.
Σp-value by chi-square statistics.AIDS Research and Therapy 2006, 3:17 http://www.aidsrestherapy.com/content/3/1/17
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Some studies have demonstrated differences in how
women of color view their bodies in comparison to Cau-
casian women [20]. However, a recent study evaluating
whether ethnicity predicted acceptance of higher body
weight among 801 women (24% Asian, 47% Hispanic,
16% black, 13% white) from a wide range of ages, body
weights, and educational backgrounds only found lower
body dissatisfaction among Asian women as compared to
women of other ethnicities [21], verifying prior investiga-
tors' findings [22-24]. Of note, there were no demon-
strated differences in body size ideals among Black,
Hispanic, and white, non-Hispanic women [21]. Our
analyses similarly did not identify ethnicity (categorized
as white vs. non-white) as a modifier of reported results.
In our cohort, HIV-infected women with lipodystrophy
were more likely to feel that their HIV status was discern-
ible by their body changes as compared to HIV-infected
women without lipodystrophy. We and others have
reported similar findings among other HIV-infected pop-
ulations [8,25]. Despite its increasing prevalence, HIV dis-
ease remains a social stigma [26-30]. The fear of HIV
status discovery as revealed by overt body changes accom-
panied by the shame and fear of discrimination associated
with HIV disease [31-33]may thus explain the heightened
body image dysphoria and lower quality of life among
women with HIV lipodystrophy.
Medication effects on the body and body image are often
listed as reasons for non-adherence among consumers,
and particularly female consumers [34]. This is similarly
true for HIV-infected patients, where lipodystrophy has
been demonstrated to have a detrimental impact on med-
ical compliance with antiretroviral therapy [35-37]. In
order to provide early intervention and perhaps improved
outcome, routine body image screening procedures
should be instituted to provide the clinician with a stand-
ardized method to better understand the full spectrum of
body image concerns that patients experience and to
increase and improve communication between physician
and patient. In the setting of HIV infection, our findings
suggest that body image concerns should be addressed
and discussed between physician and patient when select-
ing initial antiretroviral regimens.
Interpretation of our results is subject to a number of lim-
itations. First, this was a cross-sectional evaluation. As a
result, we were not able to compare how lipodystrophy
directly affects body image by assessing body image
before and after somatic changes. Second, what is referred
to as lipodystrophy syndrome is not a homogeneous
entity and varies in severity. Nevertheless, lipodystrophy
status in our study was defined both by subject and physi-
cian with good concordance, and regardless of the
method of definition, HIV-infected women with lipodys-
trophic changes were found to have significant heighten-
ing of their situational anxiety regarding their body and
reduction in their body image related quality of life as
compared to HIV-infected women without lipodystrophic
changes. However, by ascertaining lipodystrophy pres-
ence in a binary fashion (presence or absence) or in a
directional fashion (hypertrophy, atrophy, and no
change), the relationship between degrees of lipodystro-
phy and magnitude of body image change could not be
evaluated. Fourth, there remains a significant portion of
variability not explained by our current model. Further
study is therefore needed to better assess the relationship
between HIV status, lipodystrophy status, and body image
and the contribution of HIV and lipodystrophy to the
deterioration of body image among women.
Conclusion
In conclusion, notable body image dysphoria and situa-
tional anxiety is demonstrated in women with HIV dis-
Table 2: Patient Reported Site-Specific Fat Changes and Body 
Image Scale Scores
Body Site Fat Change (n) SIBID-S BIQLI
Face Fat Hypertrophy (12) 2.7 (2.3, 2.9)** -0.8 (-1.3, 0.5)*
Fat Atrophy (12) 2.6 (2.0, 3.1)** -1.0 (-1.3, -0.2)
No Change (38) 1.7 (0.6, 2.2) 0 (-0.8, 0.4)
Neck Fat Hypertrophy (15) 2.3 (2.1, 2.8)* -1.0 (-1.3, 0)
Fat Atrophy (1) 3.1** 1.7
No Change (46) 1.9 (0.8, 2.5) -0.2 (-0.9, 0.4)
Arm Fat Hypertrophy (6) 2.3 (1.9, 3.0) -0.7 (-1.2, 0.8)
Fat Atrophy (17) 2.5 (2.1, 3.0)** -0.8 (-1.3, 0.2)*
No Change (39) 1.8 (0.5, 2.4) -0.1 (-0.8, 0.6)
Breast Fat Hypertrophy (18) 2.7 (2.0, 3.0)** -1.0 (-1.3, -
0.2)**
Fat Atrophy (6) 2.4 (1.9, 3.0) 0.9 (-1.0, 2.0)
No Change (38) 1.8 (0.5, 2.3) -0.1 (-0.8, 0.4)
Abdomen Fat Hypertrophy (39) 2.3 (1.7, 2.8)** -0.7 (-1.2, 0)**
No Change (23) 1.3 (0.5, 2.3) 0.2 (-0.4, 0.8)
Leg Fat Hypertrophy (8) 2.3 (2.1, 3.2)* -0.8 (-1.1, -0.5)*
Fat Atrophy (24) 2.3 (1.6, 2.8)* -0.5 (-1.2, 1.0)
No Change (30) 1.8 (0.5, 2.4) -0.05 (-0.9, 0.5)
Buttock Fat Hypertrophy (8) 2.5 (1.0, 2.9) -0.8 (-1.3, 1.9)
Fat Atrophy (17) 2.3 (1.9, 2.7) -0.8 (-1.2, 0.2)
No Change (37) 1.9 (0.7, 2.4) -0.1 (-0.8, 0.4)
Note: Body Image Scale scores reported as Median (IQR).
**Denotes significant difference between group medians (p < 0.025) as 
determined by Wilcoxon rank sum test comparing fat change group to 
"no change" control.
* p ≤ 0.05.AIDS Research and Therapy 2006, 3:17 http://www.aidsrestherapy.com/content/3/1/17
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ease and particularly among HIV-infected women with
lipodystrophy. The detrimental effects of antiretroviral
therapy-associated lipodystrophy on body image may
contribute to non-adherence among HIV-infected female
consumers. Universal efforts by HIV medical caregivers
should be pursued to increase recognition of body image
issues in the HIV-infected population so that timely and
appropriate intervention and support may be provided.
Methods
Participants and setting
The study protocol was approved by the University of Cal-
ifornia, San Diego Human Research Protections Program
prior to study performance. HIV-infected subjects were
recruited from an academic multidisciplinary adult HIV
clinic and via HIV community centers in San Diego. Con-
trols were recruited via another study evaluating bone
density in women. Informed consent was obtained prior
to any and all study procedures.
Questionnaires
The Body Image Quality of Life Inventory (BIQLI) is a
clinical survey instrument used to assess how an individ-
ual's body image impacts his or her life. The BIQLI uses a
7-point response format ranging from very negative (-3)
to very positive (+3) effects of body image on 19 life
domains [12,38]. The nineteen-item BIQLI is internally
consistent and has been demonstrated to converge signif-
icantly with multiple measures of body-image evaluation
as well as with body mass. The BIQLI is valuable for quan-
tifying how persons' body image experiences affect a
broad range of life domains, including sense of self, social
functioning, sexuality, emotional well-being, eating, exer-
cise, grooming, etc. The BIQLI is scored as an average
numeric score of the 19 items where a more negative score
reflects a more negative body image.
The Situational Inventory of Body-Image Dysphoria
(SIBID) is an assessment of the frequency of negative
body-image emotions across specific situational contexts.
This inventory asks respondents how often they experi-
ence body-image dysphoria or distress (according to a
numeric range of 0 (never) to 4 (always)) in each of 48
identified situations in both social and nonsocial contexts
related to such activities as exercising, grooming, eating,
intimacy, physical self-focus, and appearance alterations.
Research has confirmed that this is an internally consist-
ent, stable, and convergently valid measure of body-image
affect that is responsive to body-image therapy [39-42].
Recently, a 20-item short form of the SIBID has been val-
idated and found to correlate highly (r > .95) with the
original longer version [43]. The short form of the SIBID
(SIBID-S) was used in this study. The SIBID-S is scored as
the numeric mean score of its 20 items where a higher
score is associated with increased body image dysphoria.
In addition to the above questionnaires, subjects were
asked to identify the location of their body changes, and
to state whether others noticed their body changes and
whether they felt that their disease status was revealed to
strangers based on their body changes.
Study procedures
After study procedures were reviewed and informed con-
sent was obtained, subjects were asked to answer the self-
administered questionnaires. A physical examination was
also performed by one of two study physicians to deter-
mine presence or absence of lipodystrophy (with good
Table 3: Multiple Regression Analyses on Body Image Measures and Selected Patient Characteristics in the Entire Cohort
Dependent Variable: BIQLI, R2 = 0.15, whole model p = 0.001
Variable Estimate Standard Error p-value
Self-reported body changes due to any chronic illness (absent) -0.29 0.15 0.06
Caucasian (not Caucasian) -0.18 0.13 0.16
Age (by decade) -0.006 0.01 0.64
HIV status (negative) -0.34 0.15 0.02
Dependent Variable: SIBID-S, R2 = 0.17, whole model p = 0.0004
Variable Estimate Standard Error p-value
Self-reported body changes due to any chronic illness (absent) 0.45 0.11 <0.0001
Caucasian (not Caucasian) 0.08 0.09 0.41
Age (by decade) 0.02 0.01 0.05
HIV status (negative) -0.08 0.11 0.44
Note: The reference group is presented after each variable in parentheses. Higher BIQLI scores indicate higher body image quality of life; higher 
SIBID-S scores indicate higher body image dysphoria.AIDS Research and Therapy 2006, 3:17 http://www.aidsrestherapy.com/content/3/1/17
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inter-physician concordance demonstrated in our prior
study [8]). Subjects were also asked to categorize them-
selves as having lipodystrophy or not and to identify
where fat atrophy or hypertrophy had occurred. Among
HIV-infected subjects, additional data including most
recent CD4 count and HIV viral load were also obtained
from the medical record.
Response coding
Racial response categories included: white, black, His-
panic, Asian, or other; for the purposes of regression anal-
ysis, these groups were collapsed according to white or
non-white origin. Self-reported lipodystrophy status and
clinician-determined lipodystrophy status were coded as
present or absent. HIV disease status was coded as present
or absent. AIDS status was coded as meeting AIDS diag-
nostic criteria or not. Sexual orientation was coded as
women having sex with men (heterosexual) or other. For
regression analyses, age in years was represented by dec-
ade of life and CD4 count was coded per 100 cells/μL. HIV
plasma viral load was log10-transformed prior to analysis,
and specimens reported as "undetectable viral load" were
coded as 400 copies/mL. Patient reported body site
changes were coded as no change, fat hypertrophy, or fat
atrophy. Whether others noticed a given subject's body
changes and whether the subject believed that their dis-
ease status was revealed to strangers based on their body
changes were coded as yes or no. BIQLI and SIBID-S scores
were not modified.
Statistical analysis
Patient groups were compared according to selected meas-
ures using chi-square statistics for categorical variables
and the Kruskal-Wallis rank sum test for continuous vari-
ables. Multivariate modeling of BIQLI and SIBID-S scores
was performed entering HIV and lipodystrophy status as
covariates in order to determine the association between
HIV and lipodystrophy status and body image scale
scores. Body site specific comparisons of mean SIBID-S
and BIQLI scores according to patient reported change
(no change, fat hypertrophy, and fat atrophy) were per-
formed using Wilcoxon rank sum pair wise comparisons
between fat change groups and the "no change" group
using p-value < 0.025 as the significance level applying the
Bonferroni correction for multiple comparisons [44].
Multiple linear regression models of BIQLI and SIBID-S
scores were subsequently performed among the entire
cohort (entering demographic variables) and among HIV-
infected women only (entering site specific variables with
potential associations, defined as p ≤ 0.05). Statistical
analyses were performed using JMP 5.0 (SAS Institute,
Inc., Cary, NC).
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